INSERM - TRANSFERT SA - France 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:500-600
Total Number of Projects:300-400
2019
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:800-900
Total Number of Projects:400-500
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:700-800
Networking Rank (Reputation):500-600
2015
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:600-700
Total Number of Projects:700-800
Networking Rank (Reputation):> 1000
Partner Constancy:300-400
Project Leadership Index:600-700
2014
Criterium:Position:
Overall Score:900-1000
Networking Rank (Reputation):900-1000
2013
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:64
Total Project Funding:200-300
Partner Constancy:42
Project Leadership Index:61
Diversity Index:39
2012
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:300-400
Total Number of Projects:64
Total Project Funding:300-400
Networking Rank (Reputation):500-600
Networking Rank (Reputation):500-600
Partner Constancy:40
Project Leadership Index:69
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:300-400
Total Number of Projects:600-700
Total Project Funding:500-600
Networking Rank (Reputation):800-900
Partner Constancy:300-400
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Total Project Funding:300-400
Networking Rank (Reputation):400-500
Partner Constancy:200-300
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:400-500
Total Number of Projects:600-700
Total Project Funding:500-600
Networking Rank (Reputation):> 1000
Partner Constancy:200-300
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Total Project Funding:400-500
Networking Rank (Reputation):500-600
Partner Constancy:100-200
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:300-400
Total Number of Projects:900-1000
Total Project Funding:400-500
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:700-800

Ranking timeline:

Project Participation Performance(2010-01-01 - 2021-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 64
As coordinator: 2
As participant: 62
Sole participant: 0
Coordinator / Participant Ratio: 0.03*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 10.245.066 620.375 2
2020 0 115.683.387 3.268.928 10
2019 0 81.341.950 1.993.343 7
2018 0 14.344.078 740.875 2
2017 0 5.979.607 351.875 1
2016 0 41.731.414 1.107.237 4
2015 0 21.630.050 1.514.491 4
2014 0 15.674.149 792.234 2
2013 5.900.720 59.723.277 3.843.620 1 9
2012 1.999.985 41.700.816 3.575.538 1 7
2011 0 25.245.825 1.669.330 5
2010 0 43.611.847 3.145.212 9

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE49
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS13
KATHOLIEKE UNIVERSITEIT LEUVEN11
COMMISSARIAT A L'ENERGIE ATOMIQUE10
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE9
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK7
CHARITE UNIVERSITAETSMEDIZIN BERLIN6
DEPARTMENT OF HEALTH6
FOLKHALSOMYNDIGHETEN6
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE6
KAROLINSKA INSTITUTE6
UNIVERSITE DE GENEVE6
CORIS BIOCONCEPT SPRL5
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM5
INSTITUTO DE SALUD CARLOS III5
KING'S COLLEGE LONDON5
MEDIZINISCHE HOCHSCHULE HANNOVER5
MEDIZINISCHE UNIVERSITAET WIEN5
PHILIPPS UNIVERSITAET MARBURG5
UNIVERSITAETSKLINIKUM HEIDELBERG5
UNIVERSITEIT MAASTRICHT5
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS4
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER4
EUROPEAN MOLECULAR BIOLOGY LABORATORY4
GOETEBORGS UNIVERSITET4
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT4
HACETTEPE UNIVERSITESI4
HOSPICES CIVILS DE LYON4
INSTITUT PASTEUR4
INSTITUTO NACIONAL DE SAUDE DR RICARDO JORGE4
ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANIISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO4
UNIVERSITAETSKLINIKUM FREIBURG4
UNIVERSITE D'AIX MARSEILLE4
UNIVERSITE DE LIEGE4
UNIVERSITEIT UTRECHT4
UNIVERSITY OF GLASGOW4
UNIVERSITY OF WALES CARDIFF4
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM3
ACADEMISCH ZIEKENHUIS GRONINGEN3
BERNHARD NOCHT INSTITUT FUER TROPENMEDIZIN3
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE3
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE3
FRIEDRICH LOEFFLER INSTITUT BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT3
FUNDACAO OSWALDO CRUZ3
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA3
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI3
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT3
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER3
MASARYKOVA UNIVERZITA3
MEDIZINISCHE UNIVERSITAT GRAZ3
MEDIZINISCHE UNIVERSITAT INNSBRUCK3
MINISTERO DELL'ISTRUZIONE DELL'UNIVERSITA' E DELLA RICERCA3
MOSAIQUES DIAGNOSTICS3
PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE3
REGION HOVEDSTADEN3
SERVICIO MADRILENO DE SALUD3
STICHTING KATHOLIEKE UNIVERSITEIT3
THE UNIVERSITY OF LIVERPOOL3
UNIVERSITAET LEIPZIG3
UNIVERSITE PARIS XII VAL DE MARNE3
UNIVERSITY COLLEGE LONDON3
UNIVERSITY OF DUNDEE3
UNIVERSITY OF NEWCASTLE UPON TYNE3
UNIVERSITY OF OSLO3
UNIVERSYTET MEDYCZNY W LODZI3
VETENSKAPSRADET SWEDISH RESEARCH COUNCIL3
VIB3
VRIJE UNIVERSITEIT BRUSSEL3
ACADEMIC MEDICAL CENTRE AMSTERDAM2
AGENCE FRANCAISE DE SECURITE SANITAIRE DES ALIMENTS2
ALBERT LUDWIGS UNIVERSITAET FREIBURG2
ARISTOTELIAN UNIVERSITY OF THESSALONIKI2
BAYER2
BIOMAY2
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG2
CELLARTIS AB2
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS2
CENTRO DE INVESTIGACION BIOMEDICA EN RED2
CHARLES UNIVERSITY PRAGUE2
DEUTSCHES ZENTRUM FUER LUFT UND RAUMFAHRT EV2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
EIDGENOESSISCHES DEPARTEMENT DES INNERN2
EUROVACC FOUNDATION2
FOLKEHELSEINSTITUTTET2
FONDAZIONE PER L ISTITUTO DI RICERCA IN BIOMEDICINA2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUNDACAO PARA A CIENCIA E A TECNOLOGIA2
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA2
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSIATRIO LA PAZ2
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA2
HEALTH PROTECTION AGENCY2
HEINRICHHEINEUNIVERSITAET DUESSELDORF2
HELLENIC PASTEUR INSTITUTE2
INSTITUT CATALA DE LA SALUT2
INSTITUT PASTEUR DE DAKAR2
INSTITUT PASTEUR DE LILLE2
ISTITUTO SUPERIORE DI SANITA2
JANSSEN PHARMACEUTICA NV2
JUSTUS LIEBIG UNIVERSITAET GIESSEN2
KLINIKUM DER UNIVERSITAET ZU KOELN2

Constancy:

Total number of partners: 984
Partner loyalty:
Frequent Partner: (> 2 projects): 337
Rare Partner: 647
Frequent / Rare Partner Ratio: 0.52

Project overview:

Start dateProjectacronymrolefundingpartners
2021-06-01Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trial RITA-MI 2participant6.583.21614
2021-03-01Working collaboratively with vulnerable women to identify the best implementation gains by screening cervical cancer more effectively in European countries CBIG-SCREENparticipant3.661.85016
2020-08-01Modern approaches for developing antivirals against SARS-CoV 2 MAD-CoV 2participant3.749.6699
2020-07-01European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases EU-RESPONSEparticipant15.719.45026
2020-04-01Corona Accelerated R&D in Europe CAREparticipant36.559.18642
2020-01-01Gene Therapy to restore lymphatic flow lymphedema TheraLymphparticipant8.064.94611
2020-01-01Immune profiling to guide host-directed interventions to cure HBV infections IP-cure-Bparticipant9.983.02913
2020-01-01Impact of exposome on the course of lung diseases REMEDIAparticipant11.134.61617
2020-01-01FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA FAIRparticipant10.162.90415
2020-01-01Brain injury in the premature born infant: stem cell regeneration research network PREMSTEMparticipant8.999.62016
2020-01-01Human Gonad Developmental Cell Atlas HUGODECAparticipant4.822.19710
2020-01-01Associative mechanisms linking a defective minipuberty to the appearance of mental and nonmental disorders: infantile NO replenishment as a new therapeutic possibility miniNOparticipant6.487.77011
2019-07-01Antibiotic Distribution and Recovery in Tissue AB-DiRecTparticipant3.429.2176
2019-03-01CARdiomyopathy in type 2 DIAbetes mellitus CARDIATEAMparticipant6.700.00021
2019-01-01European Joint Programme on Rare Diseases EJP RDparticipant55.073.83188
2019-01-01An integrative strategy of testing systems for identification of EDs related to metabolic disorders OBERONparticipant5.978.76312
2019-01-01Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics VHFMoDRADparticipant3.316.01314
2019-01-01Integrating Environment and Health Research: a Vision for the EU HERAparticipant3.097.32323
2019-01-01Advancing European Research Infrastcuture on Highly Pathogenic Agents ERINHA-Advanceparticipant3.746.80412
2018-01-01The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients EU-TRAINparticipant6.641.54613
2018-01-01Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative R-LiNKparticipant7.702.53222
2017-01-01Crimean-Congo Haemorrhagic Fever Vaccine CCHFVaccineparticipant5.979.60714
2016-10-01A global alliance for Zika virus control and prevention ZIKAllianceparticipant11.964.20956
2016-01-01Investigating the impact of meditation training on mental health and wellbeing in the ageing population MEDIT-AGEINGparticipant6.134.75611
2016-01-01European Research Infrastructure on Highly Pathogenic Agents 2 ERINHA2participant1.443.92716
2016-01-01European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates EHVAparticipant22.188.52243
2015-11-01Coordination Action in support of the sustainability and globalisation of the Joint Programming Initiative on Neurodegenerative Diseases JPsustaiNDparticipant2.043.28416
2015-09-01Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients MIROCALSparticipant5.980.43512
2015-05-01Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension ENSAT-HTparticipant7.607.33713
2015-05-01Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone FAIR-PARK-IIparticipant5.998.99415
2014-02-01Nanotherapeutics for antibiotic resistant emerging bacterial pathogens NAREBparticipant9.674.15815
2014-02-01Anti-Parasitic Drug Discovery in Epigenetics A-PARADDISEparticipant5.999.99116
2013-11-01Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders BRAINTRAINparticipant5.998.66110
2013-10-01"Clinical safety, immunogenicity and efficacy of a therapeutic vaccine that combines peptides mimicking antigen receptors on autoimmune B and T cells associated with myasthenia gravis" MYASTERIXcoordinator5.900.7205
2013-10-01"Human pluripotent stem cell differentiation, safety and preparation for therapeutic transplantation in Huntington’s disease" REPAIR-HDparticipant6.000.0009
2013-09-01Point-of-care tests to revolutionise the clinical management of patients infected by Hepatitis C virus POC-HCVparticipant5.991.4265
2013-09-01Targeting cardiac fibrosis for heart failure treatment FIBRO-TARGETSparticipant6.000.00011
2013-07-01Developing Innovative Outreach and Dialogue on responsible nanotechnologies in EU civil society NANODIODEparticipant1.899.84214
2013-03-01Biomarkers of renal graft injuries in kidney allograft recipients BIOMARGINparticipant6.000.00013
2013-02-01Heart OMics in AGEing HOMAGEparticipant12.000.00018
2013-02-01Nanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibility NANOATHEROparticipant9.833.34816
2013-01-01SYSTEMS BIOLOGY OF PATHWAYS INVOLVING BRAIN AGEING AGEDBRAINSYSBIOparticipant6.000.00014
2012-11-01Metagenomics in Cardiometabolic Diseases METACARDISparticipant11.999.99215
2012-10-01Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes DIABIL-2participant5.900.0006
2012-10-01Highlighting EU-funded Health research results via TV media and the internet HIGHLIGHTparticipant999.4906
2012-09-01Beta cell preservation via antigen-specific immunotherapy in Type 1 Diabetes: Enhanced Epidermal Antigen Delivery Systems. EE-ASIparticipant5.983.8718
2012-09-01European Network of Knowledge Transfer in Health ENTENTEcoordinator1.999.9857
2012-02-01European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke EuroHYP-1participant10.941.66538
2012-01-01Chips for Life C4Lparticipant2.876.3008
2012-01-01Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MYRparticipant2.999.49810

overview shows latest 50 from 64 projects (2010-01-01 - 2021-12-31)
A full list of projects can be found here:

Alias institution names:

  • INSERM TRANSFERT